Research Peptides in Austin, TX

Shipping research peptides to Austin

Every Austin order ships from Peptides Factory Direct as a stable lyophilized powder, packed for safe domestic transit to Austin and the wider Texas research community. Lots are third-party tested to a 99%+ purity target, with identity confirmed by mass spectrometry and purity quantified by HPLC, and a Certificate of Analysis is available on request to support Austin research records.

Research peptide categories shipped to Austin

Austin researchers can order across all seven research categories in the catalog. The table below maps each category to what it is studied for and example compounds.

Research peptides Austin researchers request most

The following compounds are frequently requested by researchers in Austin and the wider Texas area. Each profile is drawn from the published research literature and is provided for laboratory context only - all material is research-use-only and not for human or animal consumption.

Ipamorelin (selective GHRP) research

Ipamorelin is a pentapeptide and a selective growth-hormone secretagogue (a GHRP). In research it is valued for being one of the most selective GHRPs, reported to stimulate GH release with minimal effect on cortisol or prolactin compared with older GHRPs.

Research mechanism. Ipamorelin acts on the ghrelin/GH-secretagogue receptor to trigger growth-hormone release. Its selectivity is the central research interest, since it isolates the GH-release variable without confounding hormonal signals.

Selective GH-release research. Used as a clean GHRP in studies where minimizing cortisol/prolactin interference matters.

GHRH synergy models. Most often studied with CJC-1295 to amplify GH pulses.

Body-composition and recovery research. Downstream metabolic and recovery endpoints are studied in models.

How it compares. Compared with GHRP-6 and GHRP-2, Ipamorelin is studied as the most selective option with the least off-target hormonal signaling; compared with Hexarelin it is gentler but less potent.

Research pairings. Ipamorelin + CJC-1295 (no DAC) is the standard research stack for amplified, relatively clean GH release.

Reference research values. Research references commonly cite 200-300 mcg before rest periods on a 5-7 day schedule. Reference values only.

Full Ipamorelin research profile → · Growth Hormone & Muscle peptides

BPC-157 (Body Protection Compound 157) research

BPC-157 (Body Protection Compound 157) is a synthetic, stable pentadecapeptide of 15 amino acids derived from a partial sequence of a protein found in human gastric juice. In the research literature it is one of the most frequently studied "body protection" peptides because of its stability in gastric and aqueous environments and its broad activity across connective and epithelial tissue models.

Research mechanism. Research models associate BPC-157 with up-regulation of growth-factor signaling (notably the VEGFR2 pathway and FAK-paxillin signaling) that supports angiogenesis - the formation of new blood vessels - in injured tissue. It is also studied for modulation of the nitric-oxide system and for interaction with the gut-brain axis. These mechanisms are the subject of ongoing pre-clinical investigation and are reported in animal and in-vitro studies, not approved clinical indications.

Tendon and ligament repair research. A large share of BPC-157 literature examines tendon-to-bone healing, ligament models, and the tensile recovery of connective tissue after controlled injury. Researchers study it both locally (near a modeled injury site) and systemically because of its reported stability.

Gastrointestinal models. Because the parent sequence originates in gastric juice, BPC-157 is heavily studied in models of gut-lining integrity, ulceration, and inflammatory bowel conditions, where angiogenesis and epithelial repair are the variables of interest.

Inflammation and joint research. Anti-inflammatory signaling and joint-tissue models are a third common research theme, frequently paired with TB-500 in comparative stacking studies.

How it compares. Compared with TB-500, BPC-157 is studied as a faster-acting, more localized repair peptide; compared with GHK-Cu it targets connective and gut tissue rather than skin and hair. It is one of the most stability-tested peptides in the research catalog.

Research pairings. In the literature BPC-157 is most often studied alongside TB-500 (Thymosin Beta-4) for connective-tissue work, since the two are reported to act through complementary repair pathways - BPC-157 more locally and TB-500 through deeper, slower regeneration.

Reference research values. Research-reference protocols in the literature commonly cite 250-500 mcg once or twice daily over a 4-12 week study window, with some maintenance models at 250 mcg daily. These figures are reference values from published research only and are not dosing instructions for any living subject.

Full BPC-157 research profile → · Healing & Recovery peptides

Semax (BDNF nootropic) research

Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), developed in Russia. It is studied for cognitive and neuroprotective endpoints and is one of the most-cited nootropic research peptides.

Research mechanism. Semax research focuses on up-regulation of BDNF and nerve-growth-factor signaling and on modulation of monoamine systems, with interest in learning, memory, and neuroprotection endpoints.

Cognitive / focus research. Studied for attention, learning, and memory endpoints.

Neuroprotection research. Examined in models of neural stress and recovery.

BDNF-signaling research. A model compound for neurotrophic-factor studies.

How it compares. Semax is studied more for focus and BDNF, Selank more for anxiety; N-Acetyl Semax Amidate is a more potent, longer-lasting analog.

Research pairings. Semax + Selank pairs focus and anxiety endpoints in cognitive research.

Reference research values. Research references commonly cite 300-600 mcg daily across 2-4 week cycles. Reference values only.

Full Semax research profile → · Cognitive & Neurological peptides

Melanotan I (Afamelanotide) research

Melanotan I (afamelanotide) is a linear analog of alpha-MSH that is more selective than Melanotan II, studied for melanogenesis endpoints with fewer of the off-target effects reported for MT-II.

Research mechanism. Melanotan I research focuses on MC1R-mediated melanin synthesis, the pathway central to pigmentation research, with a more selective profile than the non-selective MT-II.

Pigmentation research. Studied for melanogenesis endpoints with a selective profile.

Photoprotection research. Examined in models of UV response.

Melanocortin-receptor research. A more selective MC1R model compound.

How it compares. Melanotan I is more selective and reportedly better tolerated in models than Melanotan II, with a narrower pigmentation focus.

Research pairings. Generally studied as a standalone selective melanocortin agonist.

Reference research values. Research references commonly cite a loading figure of 0.5-1 mg daily followed by 2-3 times weekly maintenance. Reference values only.

Full Melanotan I research profile → · Sexual Health & Tanning peptides

Epithalon (Epitalon) research

Epithalon (Epitalon) is a synthetic tetrapeptide based on a naturally occurring pineal peptide. It is one of the most-cited peptides in longevity research because of its reported association with telomerase activity and telomere length in study models.

Research mechanism. Epithalon research focuses on potential activation of telomerase - the enzyme that maintains telomeres - and on pineal/melatonin-axis regulation, both of which are longevity-research variables.

Telomere and longevity research. The central research theme, studying telomerase and cellular-aging endpoints.

Pineal / circadian research. Examined for melatonin-axis and sleep-regulation variables.

Cellular-aging models. Used in broad aging-research designs.

How it compares. Epithalon is studied for telomere/longevity endpoints specifically, distinguishing it from immune-focused Thymosin Alpha-1 and cognitive peptides.

Research pairings. Studied as a standalone longevity peptide, sometimes alongside Thymosin Alpha-1 in aging-research designs.

Reference research values. Research references commonly cite 1 mg daily across a 10-day cycle, repeated every 3-6 months. Reference values only.

Full Epithalon research profile → · Anti-Aging & Longevity peptides

PT-141 (Bremelanotide) research

PT-141 (Bremelanotide) is a synthetic melanocortin-receptor agonist derived from Melanotan II. It is studied for sexual-function endpoints through a central-nervous-system mechanism rather than a vascular one.

Research mechanism. PT-141 research focuses on activation of melanocortin receptors (notably MC4R) in the central nervous system, which is the distinguishing feature versus vascular mechanisms studied for other compounds.

Libido / sexual-function research. Studied for arousal endpoints in both male and female models via CNS signaling.

Melanocortin-pathway research. A model compound for MC4R signaling studies.

Centrally-mediated research. Used where a central rather than vascular mechanism is the variable.

How it compares. Unlike vascular-pathway compounds, PT-141 acts centrally; unlike Melanotan I/II it is studied primarily for sexual-function rather than tanning endpoints.

Research pairings. Generally studied as a standalone melanocortin agonist.

Reference research values. Research references commonly cite 1-2 mg administered 45-90 minutes before the modeled endpoint, used as-needed rather than daily. Reference values only.

Full PT-141 research profile → · Sexual Health & Tanning peptides

Dihexa (high-potency nootropic) research

Dihexa is a synthetic peptide derived from angiotensin IV, studied for its reported high potency in promoting synaptic connections (synaptogenesis). The literature describes it as extremely potent relative to BDNF in model systems, with limited human data.

Research mechanism. Dihexa research focuses on the hepatocyte-growth-factor / c-Met system and synaptogenesis, with interest in memory and cognition endpoints.

Synaptogenesis research. Studied for formation of new synaptic connections in models.

Memory and cognition research. Examined for learning and memory endpoints.

Neurodegeneration models. Used in exploratory neurodegeneration research.

How it compares. Dihexa is studied as far more potent than Semax/Selank in model systems but with much less data, making it a specialized research tool.

Research pairings. Generally studied as a standalone high-potency nootropic.

Reference research values. Research references commonly cite 5-10 mg daily in 4-8 week cycled windows. Reference values only - an advanced compound with limited data; use caution.

Full Dihexa research profile → · Cognitive & Neurological peptides

TB-500 (Thymosin Beta-4 fragment) research

TB-500 is a synthetic peptide corresponding to the active region of Thymosin Beta-4, a naturally occurring protein involved in actin regulation and cell migration. In research it is valued for its reported ability to travel systemically and reach tissue throughout the body rather than acting only at a local site.

Research mechanism. TB-500 research focuses on its binding to G-actin and its role in cell migration, blood-vessel formation, and the recruitment of repair cells to damaged tissue. By promoting cell motility, it is studied as a driver of slower but deeper regeneration than localized repair peptides.

Deep tissue and muscle recovery research. TB-500 is studied across muscle, tendon, and ligament models where whole-body distribution is desirable, and in flexibility and range-of-motion research.

Chronic-injury models. Its systemic profile makes it common in chronic and hard-to-reach injury models where a localized peptide would be impractical.

Stacked regeneration studies. It is the standard research partner for BPC-157 in connective-tissue regeneration protocols.

How it compares. Where BPC-157 is studied as fast and local, TB-500 is studied as slower and systemic. Researchers often choose between them based on whether whole-body distribution or site-specific action is the variable of interest.

Research pairings. TB-500 + BPC-157 is the most-studied healing pair in the literature; the two are reported to address complementary repair pathways. TB-500 is banned by WADA, a relevant note for sports-science researchers.

Reference research values. Published research references commonly cite a loading phase of 5-10 mg per week split across 2-3 administrations for 4-6 weeks, followed by a 2-5 mg per week maintenance figure. These are reference values from the literature and are not instructions for any living subject.

Full TB-500 research profile → · Healing & Recovery peptides

Tirzepatide (dual GLP-1/GIP agonist) research

Tirzepatide is a dual agonist that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. It is one of the most-studied modern metabolic research peptides because it engages two incretin pathways at once.

Research mechanism. Tirzepatide research examines combined GLP-1 and GIP signaling on insulin response, satiety, and energy handling, with the dual-pathway mechanism the central research distinction.

Weight-management research. Studied for body-weight endpoints via dual incretin signaling.

Glucose-metabolism research. Examined for combined GLP-1/GIP metabolic effects.

Comparative incretin studies. Frequently compared with semaglutide.

How it compares. Tirzepatide adds GIP activity on top of GLP-1, which is the defining contrast with single-pathway semaglutide in research.

Research pairings. Studied as a standalone dual-agonist model or compared with semaglutide.

Reference research values. Research references describe a titration model from 2.5 mg up to 15 mg weekly over several weeks. Reference values only.

Full Tirzepatide research profile → · Fat Loss & Weight Management peptides

Selank (anxiolytic nootropic) research

Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, developed in Russia. It is studied for anxiolytic (anti-anxiety) and cognitive endpoints without the sedation associated with classic anxiolytics.

Research mechanism. Selank research focuses on modulation of GABAergic and monoamine signaling and on brain-derived neurotrophic factor (BDNF) expression, with interest in anxiety and focus endpoints.

Anxiolytic research. Studied for anxiety endpoints without sedation in models.

Cognitive / focus research. Examined for attention and mental-clarity variables.

Neuroprotection and immune research. Its tuftsin lineage links it to immune-signaling studies.

How it compares. Selank is studied for anxiety endpoints where Semax is studied more for focus and BDNF; the two are complementary in cognitive research.

Research pairings. Selank + Semax is a common cognitive-research pairing (anxiety plus focus endpoints).

Reference research values. Research references commonly cite 250-500 mcg daily across 2-4 week cycles. Reference values only.

Full Selank research profile → · Cognitive & Neurological peptides

CJC-1295 (with or without DAC) research

CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It is studied in two forms: "no DAC" (also called Mod GRF 1-29), which is short-acting, and "with DAC" (Drug Affinity Complex), which binds albumin for a markedly longer half-life in research models.

Research mechanism. CJC-1295 research focuses on stimulation of the pituitary to release growth hormone in pulses. The DAC version extends the active window, while the no-DAC version produces a sharper, shorter pulse often studied alongside a GHRP such as Ipamorelin for synergistic release.

Growth-hormone release research. The central research theme is endogenous GH-pulse stimulation and the comparison of DAC vs no-DAC kinetics.

Body-composition models. It is studied for downstream effects on muscle and fat metabolism in research models.

GHRH + GHRP synergy studies. CJC-1295 + Ipamorelin is one of the most-studied research pairings for amplified GH pulses.

How it compares. The DAC form trades fewer administrations for a longer, flatter profile; the no-DAC form is studied for sharper, more physiologic pulses. Choice depends on the research kinetics of interest.

Research pairings. CJC-1295 (no DAC) + Ipamorelin is the canonical research pairing; the GHRH analog and the GHRP are reported to act through complementary receptors.

Reference research values. Research references commonly cite 200-300 mcg of the no-DAC form before rest periods on a 5-7 day schedule, or 1-2 mg of the DAC form one to two times weekly. Reference values only.

Full CJC-1295 research profile → · Growth Hormone & Muscle peptides

Kisspeptin (GnRH stimulator) research

Kisspeptin is a neuropeptide encoded by the KISS1 gene that is a key upstream regulator of the reproductive hormone axis. It is studied for its reported ability to stimulate gonadotropin-releasing hormone (GnRH) and downstream hormone signaling.

Research mechanism. Kisspeptin research focuses on activation of GnRH neurons, which drives luteinizing-hormone signaling and the broader reproductive axis - a model for fertility and hormone research.

Fertility / reproductive research. Studied for GnRH and gonadotropin endpoints.

Hormone-axis research. Examined as an upstream regulator of reproductive hormones.

Libido-signaling research. Studied for centrally-mediated reproductive endpoints.

How it compares. Kisspeptin acts upstream of GnRH itself, distinguishing it from Gonadorelin (a GnRH peptide) and HCG (an LH analog).

Research pairings. Generally studied as a standalone hormone-axis regulator.

Reference research values. Research references commonly cite 1-2 mg two to three times weekly. Reference values only.

Full Kisspeptin research profile → · Sexual Health & Tanning peptides

Research applications studied in Austin

• Selective GH-release research (Ipamorelin). Used as a clean GHRP in studies where minimizing cortisol/prolactin interference matters.
• Tendon and ligament repair research (BPC-157). A large share of BPC-157 literature examines tendon-to-bone healing, ligament models, and the tensile recovery of connective tissue after controlled injury. Researchers study it both locally (near a modeled injury site) and systemically because of its reported stability.
• Cognitive / focus research (Semax). Studied for attention, learning, and memory endpoints.
• Pigmentation research (Melanotan I). Studied for melanogenesis endpoints with a selective profile.
• Telomere and longevity research (Epithalon). The central research theme, studying telomerase and cellular-aging endpoints.

How Austin researchers order and store material

Place a one-time or recurring research order through the Peptides Factory Direct portal; checkout requires confirming you are 21 or older and buying for laboratory research only. Material ships to Austin as a stable lyophilized powder; refrigerate on arrival, reconstitute with bacteriostatic water when ready, and keep refrigerated through the research window. Products are research-use-only and not for human or animal consumption, and Austin researchers are responsible for compliance with applicable law. Open the order portal.

Why Austin researchers choose Peptides Factory Direct

What sets Peptides Factory Direct apart for Austin researchers is documentation, not claims. Each Austin order is third-party tested to a 99%+ purity target, ships with lot tracking and a COA on request, and arrives quickly by domestic carrier. The same catalog, purity standard, and research-use terms apply whether material ships to Austin or anywhere else in the US.

Nearby Texas research areas we ship to

Frequently asked questions

All Texas cities · All states · Research guides

External references: Texas (Wikipedia) · U.S. Census Bureau